DE602007010819D1 - Verringerung von übergewicht oder fettsucht - Google Patents

Verringerung von übergewicht oder fettsucht

Info

Publication number
DE602007010819D1
DE602007010819D1 DE602007010819T DE602007010819T DE602007010819D1 DE 602007010819 D1 DE602007010819 D1 DE 602007010819D1 DE 602007010819 T DE602007010819 T DE 602007010819T DE 602007010819 T DE602007010819 T DE 602007010819T DE 602007010819 D1 DE602007010819 D1 DE 602007010819D1
Authority
DE
Germany
Prior art keywords
reduction
overweight
fat support
weight gain
fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007010819T
Other languages
English (en)
Inventor
Nagy Peter Literati
Zoltan Szilvassy
Kalman Tory
Laszlo Vigh
Kalman Takacs
Jozsef Mandl
Balazs Suemegi
Sandor Bernath
Attila Kolonics
Gabor Balogh
Janos Egri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N-Gene Research Laboratories Inc
Original Assignee
N-Gene Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N-Gene Research Laboratories Inc filed Critical N-Gene Research Laboratories Inc
Publication of DE602007010819D1 publication Critical patent/DE602007010819D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fats And Perfumes (AREA)
  • Pyridine Compounds (AREA)
DE602007010819T 2006-11-02 2007-07-23 Verringerung von übergewicht oder fettsucht Active DE602007010819D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85611706P 2006-11-02 2006-11-02
US11/687,945 US7763601B2 (en) 2006-11-02 2007-03-19 Prevention and treatment of obesity
PCT/HU2007/000066 WO2008053256A1 (en) 2006-11-02 2007-07-23 Reduction of overweight or obesity

Publications (1)

Publication Number Publication Date
DE602007010819D1 true DE602007010819D1 (de) 2011-01-05

Family

ID=38592002

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007010819T Active DE602007010819D1 (de) 2006-11-02 2007-07-23 Verringerung von übergewicht oder fettsucht

Country Status (20)

Country Link
US (1) US7763601B2 (de)
EP (1) EP2089031B1 (de)
JP (1) JP2010509199A (de)
KR (1) KR20090082442A (de)
AT (1) ATE489090T1 (de)
AU (1) AU2007315931A1 (de)
BR (1) BRPI0717867A2 (de)
CA (1) CA2668382A1 (de)
DE (1) DE602007010819D1 (de)
DK (1) DK2089031T3 (de)
HK (1) HK1131737A1 (de)
HR (1) HRP20110023T1 (de)
IL (1) IL198296A (de)
MX (1) MX2009004538A (de)
NO (1) NO20092025L (de)
PL (1) PL2089031T3 (de)
PT (1) PT2089031E (de)
RU (1) RU2443417C2 (de)
SI (1) SI2089031T1 (de)
WO (1) WO2008053256A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
EP3788877A1 (de) * 2007-04-11 2021-03-10 Omeros Corporation Zusammensetzungen und verfahren zur vorbeugung und behandlung von suchtkrankheiten
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
WO2009074835A1 (en) * 2007-12-10 2009-06-18 N-Gene Research Laboratories Inc. Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1100445A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4287220A (en) * 1980-02-19 1981-09-01 Frito-Lay, Inc. Hull containing compositions
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
US6884424B2 (en) 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
US6458371B1 (en) 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
HUP9701080A3 (en) 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
AU5296799A (en) 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
UA65635C2 (uk) * 1998-09-03 2004-04-15 Н-Гене Кутато Кфт. НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ
CA2452558C (en) 2001-07-17 2009-12-22 N-Gene Research Laboratories Inc. A synergistic pharmaceutical combination for the prevention or treatment of diabetes
HUP0401177A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition for increasing the mitochondrial genesis
HUP0401176A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition having prpkinetic effect
HUP0500145A2 (en) 2005-01-28 2006-11-28 Gene Res Lab N Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
CN101534836B (zh) 2006-09-05 2011-09-28 彼帕科学公司 Parp抑制剂在制备治疗肥胖症的药物中的用途

Also Published As

Publication number Publication date
SI2089031T1 (sl) 2011-04-29
EP2089031A1 (de) 2009-08-19
IL198296A (en) 2011-09-27
BRPI0717867A2 (pt) 2013-10-29
WO2008053256A1 (en) 2008-05-08
PT2089031E (pt) 2011-02-24
NO20092025L (no) 2009-06-02
EP2089031B1 (de) 2010-11-24
DK2089031T3 (da) 2011-02-14
KR20090082442A (ko) 2009-07-30
ATE489090T1 (de) 2010-12-15
MX2009004538A (es) 2009-05-22
IL198296A0 (en) 2010-02-17
US7763601B2 (en) 2010-07-27
RU2443417C2 (ru) 2012-02-27
PL2089031T3 (pl) 2011-05-31
AU2007315931A1 (en) 2008-05-08
HK1131737A1 (en) 2010-02-05
CA2668382A1 (en) 2008-05-08
JP2010509199A (ja) 2010-03-25
RU2009119567A (ru) 2010-12-10
US20080108673A1 (en) 2008-05-08
HRP20110023T1 (hr) 2011-04-30

Similar Documents

Publication Publication Date Title
DE602007010819D1 (de) Verringerung von übergewicht oder fettsucht
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
EP1730163A4 (de) Pharmazeutische salze von 3-o-(3,3-dimethylsuccinyl)betulinsäure
UA115320C2 (uk) Інгібітори кінази
MX2013004491A (es) Boronatos como inhibidores de arginasa.
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
MX2012000414A (es) Derivados piridin-4-ilo.
WO2011127070A3 (en) IRE-1α INHIBITORS
NO20071658L (no) Alkil-pyridiner som 11-beta-inhibitorer for diabetes
PH12014501278A1 (en) Kinase inhibitors
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
IL185457A0 (en) 5-phenyl-pentanoic acid derivatives as metrix metalloproteinase inhibitors for the treatment of asthma and other diseases
WO2005123049A3 (en) A pharmaceutical composition for increasing the mitochondrial genesis
TN2012000092A1 (en) Therapeutic agent for mood disorders
ITFI20050041A1 (it) Idrossammati come inibitori dell&#39;istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
NO20092024L (no) En farmasoytisk sammensetning med antipsykotisk, antidepressiv eller antiepileptisk aktivitet med redusert bivirkning
TW200640446A (en) Prophylactic anti-stress agent
MX2009004295A (es) Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
NO20090292L (no) Fenyleddiksyrederivater
UY32894A (es) Derivados de 5-fenil-pirazolopiridina, su preparación y su aplicación en terapéutica
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії